Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
about
Sequence and analysis of the genome of the pathogenic yeast Candida orthopsilosisGenomic Plasticity of the Human Fungal Pathogen Candida albicansThe ABCs of Candida albicans Multidrug Transporter Cdr1Shift and adapt: the costs and benefits of karyotype variationsFluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine CryptococcosisInhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole ResistanceHeteroresistance of Cryptococcus gattii to fluconazole.The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.Variation in chromosome copy number influences the virulence of Cryptococcus neoformans and occurs in isolates from AIDS patients.The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibilityAntimicrobial peptides: therapeutic potential for the treatment of Candida infections.Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicansAntifungal activity of C-27 steroidal saponins.Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans.Pharmacotherapy of Candida bloodstream infections: new treatment options, new era.Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agentsAn update on antifungal targets and mechanisms of resistance in Candida albicans.Role of DNA mismatch repair and double-strand break repair in genome stability and antifungal drug resistance in Candida albicans.Micafungin activity against Candida albicans with diverse azole resistance phenotypes.Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistanceABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patientsHeteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?Mechanisms of Antifungal Drug Resistance.The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.Heteroresistance and fungi.Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans.Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.Susceptibility of Candida species to photodynamic effects of photofrin.Update on Antifungal Drug Resistance.In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp.Transcriptional profiling of azole-resistant Candida parapsilosis strainsTrailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases.Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.
P2860
Q21561002-AF3E65D7-EFB6-4429-99F5-75A417C24A8CQ21999033-62C6F9E3-4F5D-4E14-9D36-EE363FC10D66Q26786747-8997FDF1-7ED9-4C4A-99CE-8CE05AEB879EQ26796267-FF3B7E97-4A2D-4C23-A508-69B41D882448Q28544939-B2B3C9D9-B6D9-40F4-91D9-20B990A98361Q28547078-C8D1C548-1EAA-4719-87B5-48EF546765B7Q33876577-D8730805-D9F6-4DB2-911E-78B27707B145Q33887429-845E7603-C709-456B-9996-AA4DE1467B12Q33981896-95F8099A-4563-4680-B665-BA044E9831B1Q34059795-6A5263CD-8115-4C59-9225-A5B2AEB609EAQ34112865-1BBF7AA0-972B-4CBD-9916-3A7D24A23804Q34510707-20757A20-2E78-43ED-BBBC-5557855F40F2Q34519189-29F38E22-66FF-4891-BF85-2FCF465739D6Q34561878-E1F69165-8CAF-4930-ABFE-E635D19D2F6EQ34588684-06681A76-2930-489F-9E38-35CC99D5E279Q34648545-215B4301-8D62-4702-B719-F54C8F0CEE78Q34721695-8CAF70BB-52CA-43C2-9C0B-1133545579A5Q34768471-8CD6CED6-F102-4EF9-9039-A42E04143C2FQ35073460-532F3EB0-076A-4869-98A9-4787D7221418Q35690629-309E2AB3-BB92-4BD0-A2C9-484A12888D7AQ36235037-0977D379-BF85-4588-8590-F7FDA3AF4DB2Q36313742-1C9A9B28-0928-426D-8F4E-762B0E4945B7Q36867925-033894F1-ED73-4091-81D4-B2660CE5F802Q36925967-0C1E3977-13AE-4AE6-919A-C0265B2A7F4FQ36949532-59C212B0-777C-4A01-8E0A-934944A765ACQ37052163-4E15757C-5E64-405F-951C-C429EB476A2AQ37247728-52F5B851-18BF-4885-81E9-5549C30B726DQ37734345-61F5E54D-EFCD-4723-846E-3AC1EC162694Q37866827-B2F2F928-EC36-408D-A9CF-358C3F8B55BEQ38266675-7200B843-0618-480B-A25F-F8C3BA8C6455Q38752384-CB21EE22-60D8-48C2-B395-2BC8720C9B00Q39404146-D3479794-9D69-4105-8935-D7DB34167F5FQ39732812-AA689864-4923-4240-8A7F-91931254860DQ39954432-0B8195BB-7234-4050-A7E6-858A1B19E299Q40882683-749ABCF9-0358-434D-8F71-D3D33CD163C8Q41135029-9AF43E8D-EFFB-4BF6-B70E-1C38BAE9575EQ41559415-2116AA86-2439-482A-9068-C4DA16A479F3Q42110990-2A468C70-C0CF-4963-9991-AB81C72C8725Q43299773-70490076-D622-4567-B2C9-F34AC4A65784Q43716683-B126517D-950B-4CF3-BF67-7DCB3BE39482
P2860
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
@en
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
@nl
type
label
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
@en
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
@nl
prefLabel
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
@en
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
@nl
P2093
P2860
P1476
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans
@en
P2093
P2860
P356
10.1128/AAC.45.1.52-59.2001
P407
P577
2001-01-01T00:00:00Z